Apeloa Pharmaceutical Co Ltd banner
A

Apeloa Pharmaceutical Co Ltd
SZSE:000739

Watchlist Manager
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Watchlist
Price: 18.17 CNY -2.05%
Market Cap: ¥21B

Relative Value

The Relative Value of one Apeloa Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 18.17 CNY, Apeloa Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Apeloa Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Apeloa Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Apeloa Pharmaceutical Co Ltd
SZSE:000739
21B CNY 2 24.4 21.4 21.4
US
Eli Lilly and Co
NYSE:LLY
993.5B USD 15.2 48.1 32.4 34.5
US
Johnson & Johnson
NYSE:JNJ
590.8B USD 6.3 22 15.3 18.8
CH
Roche Holding AG
SIX:ROG
292.8B CHF 4.8 31.3 13.2 15.4
UK
AstraZeneca PLC
LSE:AZN
237.2B GBP 5.5 31.7 17.5 24.6
CH
Novartis AG
SIX:NOVN
244.9B CHF 5.6 22.6 13.9 17.9
US
Merck & Co Inc
NYSE:MRK
307.1B USD 4.7 16.8 10.5 12.3
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK 3.7 11.3 8.3 9.8
US
Pfizer Inc
NYSE:PFE
153.9B USD 2.5 19.8 7.4 9.9
US
Bristol-Myers Squibb Co
NYSE:BMY
123.1B USD 2.6 17.5 7.3 9
P/E Multiple
Earnings Growth PEG
CN
A
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Average P/E: 24.5
24.4
12%
2
US
Eli Lilly and Co
NYSE:LLY
48.1
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22
7%
3.1
CH
Roche Holding AG
SIX:ROG
31.3
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.7
26%
1.2
CH
Novartis AG
SIX:NOVN
22.6
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.8
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
7%
1.6
US
Pfizer Inc
NYSE:PFE
19.8
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.5
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
A
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Average EV/EBITDA: 43.7
21.4
27%
0.8
US
Eli Lilly and Co
NYSE:LLY
32.4
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.3
2%
7.6
CH
Roche Holding AG
SIX:ROG
13.2
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.5
11%
1.6
CH
Novartis AG
SIX:NOVN
13.9
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.5
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.3
7%
1.2
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.3
-12%
N/A